The BRCT 1 trial allowed for the addition of glucocorticoids to the study agent (thiopental or placebo) at the discretion of the treating physician. This arm of the BRCT 1 was not controlled, and the data was analyzed retrospectively (19). The inclusion criteria and the primary outcome measure were identical to the thiopental study. The choice of glucocorticoid, either dexametha-zone or methylprednisolone, was dependent on the treatment preference of the center and was administered during the first 8 hours post ROSC. The glucocorticoid treatment doses were divided into no dose, low dose (1-20 mg of dexamethazone), medium dose (21-70 mg of dex-amathazone), and high dose (equivalent >70 mg of dexamathazone). The percentage of patients with good outcome (CPC 1 and 2) was similar for all dose groups, which ranged from 34.0% to 37.3% ( 19 ).

Metabolism Masterclass

Metabolism Masterclass

Are You Sick And Tired Of All The Fat-Burning Tricks And Trends That Just Don’t Deliver? Well, Get Set To Discover The Easy, Safe, Fast, And Permanent Way To Mega-Charge Your Metabolism And Lose Excess Fat Once And For All! This Weight Blasting Method Is Easy AND Natural… And Will Give You The Hot Body And Killer Energy Levels You’ve Been Dreaming Of.

Get My Free Ebook

Post a comment